Tissue engineered skin substitutes are
cellular and acellular materials that aid in the healing of damaged skin
by releasing cytokines and growth factors at the wound site. Skin
substitutes or artificial skin substitute are derived from human tissue,
non-human tissue, synthetic materials, and combination of the above
materials. This report studies the current scenario as well as future
market potential for tissue engineered skin substitutes globally. This
report comprises an elaborate executive summary, which includes a market
snapshot that provides market dynamics of various segments and
sub-segments that are included in the report in a precise manner.
Moreover, executive summary comprises waterfall diagram, which reflects
the market size of various segments in descending order.
A detailed qualitative analysis of the
factors responsible for driving and restraining the growth of the global
tissue engineered skin substitutes market and future opportunities has
been provided in the market overview section. This section of the report
also provides market attractiveness analysis, Porter’s Five Forces
analysis, and market share analysis by key players (%) operating in the
tissue engineered skin substitutes market.
Based on type, the global tissue
engineered skin substitutes market has been segmented into acellular,
cellular allogeneic, cellular autologous and others. The market for
these types has been extensively analyzed based on consistency,
effectiveness, and sales revenue of the various products developed by
the manufacturers. The market size and forecast in terms of USD million
for each type has been provided for the period from 2013 to 2023. The
report on the tissue engineered skin substitutes market also provides
compound annual growth rate (CAGR %) for each of the market segments
mentioned above for the forecast period from 2015 to 2023, considering
2014 as the base year.
Based on application, the global tissue
engineered skin substitutes market has been segmented into burn injury,
diabetic/vascular ulcer and others. The market for these types has been
extensively analyzed based on consistency, effectiveness, and sales
revenue of the various products developed by the manufacturers. The
market size and forecast in terms of USD million for each product
(category) has been provided for the period from 2013 to 2023. The
report on the tissue engineered skin substitutes market also provides
compound annual growth rate (CAGR %) for each of the market segments
mentioned above for the forecast period from 2015 to 2023, considering
2014 as the base year.
Geographically, the tissue engineered
skin substitutes market has been categorized into North America, Europe,
Asia-Pacific, Latin America, and Middle East and Africa. The market
size and forecast for each of these regions have been provided for the
period from 2013 to 2023 along with CAGR (%) for the forecast period
from 2013 to 2023. The research study also incorporates the competitive
scenario of major players in these regions.
A list of recommendations has been
provided for new entrants to help establish a strong presence and for
existing market players to increase their market shares. The report
concludes with the profiles of major players in the tissue engineered
skin substitutes market based on various attributes such as company
overview, financial overview, business strategies, product portfolio,
and recent developments. Major players profiled in this report include
3M Health Care, BSN medical, Medtronic, Acelity, L.P., Inc., Mölnlycke
Health and Integra LifeSciences Corporation.
No comments:
Post a Comment